Novel function of complement C3d as an autologous helper T‐cell target

Publisher Website
Google Scholar
Abstract
The C3d fragment of complement component C3 has been shown to enhance immune responses to antigens that lack T‐cell epitopes such as bacterial polysaccharides. C3d binds to the B‐cell complement receptor 2 (CR2 or CD21); this binding serves as a co‐activation signal to the B cell when the polysaccharide antigen portion binds simultaneously to the B‐cell receptor (surface Ig). Bringing together receptor‐associated signal transduction molecules CD19 and Igα/β, respectively, results in a lower threshold of activation. Paradoxically, C3d has also been shown to enhance antibody titers in the CD21 knockout (KO) mouse model as well as increase Th1 and Th2 cytokine secretion, suggesting that that an auxiliary CR2‐independent pathway of immune activation may exist. We hypothesized that in addition to its molecular adjuvant property that enhances signal 1 during B‐cell activation (co‐signal 1), C3d also contains T‐cell epitopes that are able to stimulate autoreactive C3d peptide‐specific helper T cells which we term ‘co‐signal 2’. Using the EpiMatrix T‐cell epitope‐mapping algorithm, we identified 11 putative T‐cell epitopes in C3d, a very high epitope density for a 302 amino‐acid sequence. Eight of these epitope candidates were synthesized and shown to bind a variety of class II HLA‐DR molecules of different haplotypes, and to stimulate C3d peptide‐specific T cells to secrete pro‐inflammatory cytokines in vitro. Further, we demonstrate a C3d‐peptide specific increase in CD4+ intracellular IFN‐γ+ T cells in peripheral blood mononuclear cells (PBMCs) exposed to C3d peptides in vitro. We believe that the discovery of these autologous T cells autoreactive for C3d provides evidence supporting the ‘co‐signal 2’ hypothesis and may offer a novel explanation of the CD21 KO paradox.
Funding Information
  • EpiVax Inc